Journal article
Long-Term Burden of Breast Cancer-Related Lymphedema
Current breast cancer reports, Vol.16(2), pp.251-259
06/2024
DOI: 10.1007/s12609-024-00539-0
Abstract
Purpose of ReviewBreast cancer-related lymphedema (BCRL) remains a significant burden for breast cancer survivors. With improved survival, recognition of the long-term burden of BCRL on patients is increasingly important.Recent FindingsSurveillance for BCRL is recommended by expert consensus guidelines, with detection of early BCRL associated with lower rates of persistent disease; however, currently, there are no recommendations regarding frequency nor duration. Formal guidelines may reduce the long-term burden of worry for patients. Once BCRL develops, patients experience the life-long burden of managing a chronic disease, including remaining compliant with complex therapy and negative effects on quality of life. With long-term treatment also comes significant financial toxicity through direct cost of treatment and indirect costs, including loss of productivity and income.SummaryThe long-term burdens of BCRL exist in all who need surveillance and in those with BCRL as chronic disease management, worse quality of life, and financial toxicity.
Details
- Title: Subtitle
- Long-Term Burden of Breast Cancer-Related Lymphedema
- Creators
- Anna C. Beck - Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53726 USAIngrid M. Lizarraga - Univ Iowa, Hosp & Clin, Dept Surg, Div Surg Oncol, Rm 4636 JCP,200 Hawkins Dr, Iowa City, IA 52242 USA
- Resource Type
- Journal article
- Publication Details
- Current breast cancer reports, Vol.16(2), pp.251-259
- DOI
- 10.1007/s12609-024-00539-0
- ISSN
- 1943-4588
- eISSN
- 1943-4596
- Publisher
- Springer Nature
- Number of pages
- 9
- Language
- English
- Electronic publication date
- 03/25/2024
- Date published
- 06/2024
- Academic Unit
- Surgery
- Record Identifier
- 9984584908902771
Metrics
8 Record Views